Eli Lilly Drug Cymbalta for Chronic Pain

Eli Lilly resubmitted an application for U.S. Food and Drug Administration (FDA) approval in June 2009 for the treatment of chronic pain with Cymbalta (duloxetine). Cymbalta is already approved for the treatment of depression, anxiety, fibromyalgia, and diabetic neuropathy.

Advertisement